Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/19901116

J. Clin. Oncol. 2009 Dec 20 27 36 6152-9

Download in:

View as

General Info

PMID
19901116